Kapnick Scott 13D and 13G filings for Aileron Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 07:54 am Sale | 2022-12-31 | 13G | Aileron Therapeutics, Inc. ALRN | Kapnick Scott | 379,608 8.400% | -3 (-0.00%) | Filing |
| 2022-02-14 09:02 am Purchase | 2021-12-31 | 13G | Aileron Therapeutics, Inc. ALRN | Kapnick Scott | 379,611 8.400% | 210,750 (+124.81%) | Filing |
| 2020-06-08 5:16 pm Purchase | 2019-04-02 | 13G | Aileron Therapeutics, Inc. ALRN | Kapnick Scott | 168,861 8.800% | 168,861 (New Position) | Filing |